Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Boston Therapeutics, Inc. | f10q0321ex31-1_bostontherap.htm |
| 10-Q - QUARTERLY REPORT - Boston Therapeutics, Inc. | f10q0321_bostontherapeutics.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Boston Therapeutics, Inc. (the “Company”) for the quarter ending March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Conroy Chi-Heng Cheng, Chief Executive and Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
| (1) | The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: June 14, 2021 | By: | /s/ Conroy Chi-Heng Cheng |
| Conroy Chi-Heng Cheng | ||
| Chief Executive Officer | ||
| (Principal Executive, Financial and Accounting Officer) |